Risk of osteoporotic fractures in new users of denosumab compared with new users of alendronate: A Danish populationbased cohort study
Հիմնական հեղինակներ: | Pedersen, AB, Heide-Jorgensen, U, Sorensen, HT, Prieto-Alhambra, D, Ehrenstein, V |
---|---|
Ձևաչափ: | Conference item |
Հրապարակվել է: |
Wiley
2018
|
Նմանատիպ նյութեր
-
Comparison of risk of osteoporotic fracture in Denosumab vs Alendronate treatment within 3 years of initiation
: Pedersen, AB, և այլն
Հրապարակվել է: (2019) -
The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
: Rikke Viggers, և այլն
Հրապարակվել է: (2022-01-01) -
Danish clinical quality databases – an important and untapped resource for clinical research
: Sørensen HT, և այլն
Հրապարակվել է: (2016-10-01) -
Denosumab for the prevention of osteoporotic fractures in postmenopausal women
: N Waugh, և այլն
Հրապարակվել է: (2011-05-01) -
Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users.
: Eiken, P, և այլն
Հրապարակվել է: (2017)